Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantine Frangakis

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
The American Journal of Psychiatry|April 2, 2016
Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD StudyAnne K Leonpacher, Matthew E Peters, Lea T Drye, et al.
Plos One|June 11, 2014
Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trialLea T Drye, David Spragg, D P Devanand, et al.
International Psychogeriatrics|August 26, 2015
Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trialPaul B Rosenberg, Lea T Drye, Anton P Porsteinsson, et al.
The American Journal of Psychiatry|January 16, 2016
Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical TrialLon S Schneider, Constantine Frangakis, Lea T Drye, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
The American Journal of Psychiatry|April 2, 2016
Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD StudyAnne K Leonpacher, Matthew E Peters, Lea T Drye, et al.
Plos One|June 11, 2014
Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trialLea T Drye, David Spragg, D P Devanand, et al.
International Psychogeriatrics|August 26, 2015
Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trialPaul B Rosenberg, Lea T Drye, Anton P Porsteinsson, et al.
The American Journal of Psychiatry|January 16, 2016
Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical TrialLon S Schneider, Constantine Frangakis, Lea T Drye, et al.
Pageof 9